pharma-话题@MedSci

#pharma#

608篇内容 | 2522人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1908530, encodeId=5c221908530c1, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Forendo Pharma成功完成FOR-6219的1a期临床试验，用于治疗子宫内膜异位症, objectType=article, longId=161876, objectId=6f061618e6bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f061618e6bb, replyNumber=0, likeNumber=57, createdTime=2019-05-19, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f061618e6bb, moduleTitle=Forendo Pharma成功完成FOR-6219的1a期临床试验，用于治疗子宫内膜异位症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f061618e6bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908462, encodeId=f2251908462e6, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacotherapy：QTc间期风险预测模型可否预测QTc间期延长风险？, objectType=article, longId=148425, objectId=b3f714842595, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3f714842595, replyNumber=0, likeNumber=49, createdTime=2019-08-22, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3f714842595, moduleTitle=Pharmacotherapy：QTc间期风险预测模型可否预测QTc间期延长风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3f714842595)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908505, encodeId=ce8619085056d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：在前列腺癌细胞中，miR-195对MAP2K1的靶向调控能够抑制ADM药物抗性, objectType=article, longId=157435, objectId=d46015e435bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d46015e435bf, replyNumber=0, likeNumber=74, createdTime=2019-04-30, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d46015e435bf, moduleTitle=Eur Rev Med Pharmacol Sci：在前列腺癌细胞中，miR-195对MAP2K1的靶向调控能够抑制ADM药物抗性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d46015e435bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908441, encodeId=76221908441d1, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur J Pharmacol：7,8,3''''-三羟基黄酮可改善体内氧化应激并促进视网膜神经节细胞的神经突再生, objectType=article, longId=141742, objectId=6567141e424e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6567141e424e, replyNumber=0, likeNumber=124, createdTime=2019-03-29, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6567141e424e, moduleTitle=Eur J Pharmacol：7,8,3''''-三羟基黄酮可改善体内氧化应激并促进视网膜神经节细胞的神经突再生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6567141e424e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908482, encodeId=16dc190848255, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=J Clin Pharmacol：在前列腺癌患者中，雄激素阻断治疗能够增加心脏衰竭的风险, objectType=article, longId=154190, objectId=ce141541905c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce141541905c, replyNumber=0, likeNumber=60, createdTime=2019-07-03, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce141541905c, moduleTitle=J Clin Pharmacol：在前列腺癌患者中，雄激素阻断治疗能够增加心脏衰竭的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce141541905c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908443, encodeId=f035190844344, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：儿茶酸能够减轻过敏性鼻炎炎症, objectType=article, longId=142008, objectId=87df14200822, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87df14200822, replyNumber=0, likeNumber=68, createdTime=2018-11-19, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87df14200822, moduleTitle=Int Immunopharmacol：儿茶酸能够减轻过敏性鼻炎炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87df14200822)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908467, encodeId=ce18190846ecf, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=GW Pharma的大麻二酚活性药物Epidiolex即将在美国上市, objectType=article, longId=149981, objectId=ec3b14998109, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec3b14998109, replyNumber=0, likeNumber=92, createdTime=2018-11-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec3b14998109, moduleTitle=GW Pharma的大麻二酚活性药物Epidiolex即将在美国上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec3b14998109)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908429, encodeId=3b2b190842919, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Mol Pharmacol：饶毅实验室发文：提出全新证据五羟色胺参与睡眠, objectType=article, longId=139213, objectId=6bcd13921352, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bcd13921352, replyNumber=0, likeNumber=48, createdTime=2018-08-11, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bcd13921352, moduleTitle=Mol Pharmacol：饶毅实验室发文：提出全新证据五羟色胺参与睡眠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bcd13921352)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908522, encodeId=043d19085229e, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Acta Pharmacol Sin：中国人群血清尿酸水平与骨质疏松症和骨转换指标的关系, objectType=article, longId=160253, objectId=1d6b160253fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d6b160253fa, replyNumber=0, likeNumber=68, createdTime=2019-05-07, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d6b160253fa, moduleTitle=Acta Pharmacol Sin：中国人群血清尿酸水平与骨质疏松症和骨转换指标的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d6b160253fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908520, encodeId=572f190852018, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：二甲双胍通过GSK3β抑制促进人骨髓间充质干细胞向成骨细胞的分化, objectType=article, longId=159625, objectId=3872159625d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3872159625d1, replyNumber=0, likeNumber=66, createdTime=2020-01-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3872159625d1, moduleTitle=Eur Rev Med Pharmacol Sci：二甲双胍通过GSK3β抑制促进人骨髓间充质干细胞向成骨细胞的分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3872159625d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908519, encodeId=ba8c190851993, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：富含类黄酮的佛手柑汁提取物改善脂多糖诱导的牙周炎, objectType=article, longId=159590, objectId=c3a1159590ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3a1159590ca, replyNumber=0, likeNumber=76, createdTime=2020-01-13, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3a1159590ca, moduleTitle=Front Pharmacol：富含类黄酮的佛手柑汁提取物改善脂多糖诱导的牙周炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3a1159590ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908422, encodeId=cac519084221c, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：研究揭示异柠檬酸内酯C在葡萄膜炎和视网膜炎性疾病中的治疗作用机制, objectType=article, longId=138307, objectId=b26713830e7a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b26713830e7a, replyNumber=0, likeNumber=91, createdTime=2018-07-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b26713830e7a, moduleTitle=Front Pharmacol：研究揭示异柠檬酸内酯C在葡萄膜炎和视网膜炎性疾病中的治疗作用机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b26713830e7a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908516, encodeId=df21190851678, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：IL-37能够通过STAT6/STAT3减弱过敏性鼻炎中的过敏过程, objectType=article, longId=159532, objectId=40331595327d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40331595327d, replyNumber=0, likeNumber=121, createdTime=2019-07-02, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40331595327d, moduleTitle=Int Immunopharmacol：IL-37能够通过STAT6/STAT3减弱过敏性鼻炎中的过敏过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40331595327d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908416, encodeId=c02a1908416a2, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=J Anaesthesiol Clin Pharmacol：右美托咪定静脉负荷用药或负荷加维持用药用于重比重布比卡因腰麻的效果, objectType=article, longId=135858, objectId=d88f13585837, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d88f13585837, replyNumber=0, likeNumber=75, createdTime=2018-10-06, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d88f13585837, moduleTitle=J Anaesthesiol Clin Pharmacol：右美托咪定静脉负荷用药或负荷加维持用药用于重比重布比卡因腰麻的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d88f13585837)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908495, encodeId=b43e190849507, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？, objectType=article, longId=156509, objectId=fcba1565093c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcba1565093c, replyNumber=0, likeNumber=53, createdTime=2019-05-09, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcba1565093c, moduleTitle=Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcba1565093c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908532, encodeId=15451908532d3, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：可溶性环氧化物水解酶抑制眼部疾病的展望, objectType=article, longId=162987, objectId=922416298e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=922416298e0b, replyNumber=0, likeNumber=52, createdTime=2019-04-16, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=922416298e0b, moduleTitle=Front Pharmacol：可溶性环氧化物水解酶抑制眼部疾病的展望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=922416298e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908513, encodeId=b67219085133f, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Destiny Pharma：有关XF-73 I期试验的积极数据, objectType=article, longId=159193, objectId=26d71591933c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26d71591933c, replyNumber=0, likeNumber=67, createdTime=2019-09-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26d71591933c, moduleTitle=Destiny Pharma：有关XF-73 I期试验的积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26d71591933c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908493, encodeId=b16a19084935b, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Clin Pharmacol Ther：干货！严重急性营养不良婴幼儿头孢曲松和甲硝唑给药剂量知多少, objectType=article, longId=156114, objectId=fd11156114e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd11156114e4, replyNumber=0, likeNumber=67, createdTime=2019-03-30, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd11156114e4, moduleTitle=Clin Pharmacol Ther：干货！严重急性营养不良婴幼儿头孢曲松和甲硝唑给药剂量知多少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd11156114e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908700, encodeId=903e1908e00f2, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacotherapy：冠心病：他汀联用ACEI还是ARB更有效？, objectType=article, longId=156867, objectId=2b1a15686e00, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b1a15686e00, replyNumber=0, likeNumber=68, createdTime=2019-03-02, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b1a15686e00, moduleTitle=Pharmacotherapy：冠心病：他汀联用ACEI还是ARB更有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b1a15686e00)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908442, encodeId=88871908442e5, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？, objectType=article, longId=141968, objectId=8ab4141968fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ab4141968fd, replyNumber=0, likeNumber=83, createdTime=2018-07-26, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ab4141968fd, moduleTitle=Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ab4141968fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

pharma

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#pharma#

Forendo Pharma成功完成FOR-6219的1a期临床试验，用于治疗子宫内膜异位症

2019-05-19

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacotherapy：QTc间期风险预测模型可否预测QTc间期延长风险？

2019-08-22

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：在前列腺癌细胞中，miR-195对MAP2K1的靶向调控能够抑制ADM药物抗性

2019-04-30

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur J Pharmacol：7,8,3''''-三羟基黄酮可改善体内氧化应激并促进视网膜神经节细胞的神经突再生

2019-03-29

chentianping (审核中...)

前往app查看评论内容

#pharma#

J Clin Pharmacol：在前列腺癌患者中，雄激素阻断治疗能够增加心脏衰竭的风险

2019-07-03

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：儿茶酸能够减轻过敏性鼻炎炎症

2018-11-19

chentianping (审核中...)

前往app查看评论内容

#pharma#

GW Pharma的大麻二酚活性药物Epidiolex即将在美国上市

2018-11-15

chentianping (审核中...)

前往app查看评论内容

#pharma#

Mol Pharmacol：饶毅实验室发文：提出全新证据五羟色胺参与睡眠

2018-08-11

chentianping (审核中...)

前往app查看评论内容

#pharma#

Acta Pharmacol Sin：中国人群血清尿酸水平与骨质疏松症和骨转换指标的关系

2019-05-07

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：二甲双胍通过GSK3β抑制促进人骨髓间充质干细胞向成骨细胞的分化

2020-01-01

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：富含类黄酮的佛手柑汁提取物改善脂多糖诱导的牙周炎

2020-01-13

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：研究揭示异柠檬酸内酯C在葡萄膜炎和视网膜炎性疾病中的治疗作用机制

2018-07-04

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：IL-37能够通过STAT6/STAT3减弱过敏性鼻炎中的过敏过程

2019-07-02

chentianping (审核中...)

前往app查看评论内容

#pharma#

J Anaesthesiol Clin Pharmacol：右美托咪定静脉负荷用药或负荷加维持用药用于重比重布比卡因腰麻的效果

2018-10-06

chentianping (审核中...)

前往app查看评论内容

#pharma#

Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？

2019-05-09

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：可溶性环氧化物水解酶抑制眼部疾病的展望

2019-04-16

chentianping (审核中...)

前往app查看评论内容

#pharma#

Destiny Pharma：有关XF-73 I期试验的积极数据

2019-09-15

chentianping (审核中...)

前往app查看评论内容

#pharma#

Clin Pharmacol Ther：干货！严重急性营养不良婴幼儿头孢曲松和甲硝唑给药剂量知多少

2019-03-30

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacotherapy：冠心病：他汀联用ACEI还是ARB更有效？

2019-03-02

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？

2018-07-26

科室
- - 订阅+
  - 更多科室
工具
服务